Cargando…
Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma
Basal cell carcinoma (BCC) of the skin is the most common type of cancer and accounts for up to 40% of all cancers in the US, with a growing incidence rate over recent decades in all developed countries. Surgery is curative for most patients, although it leaves unaesthetic scars, but those that deve...
Autores principales: | Cucchi, Danilo, Occhione, Maria Anna, Gulino, Alberto, De Smaele, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863577/ https://www.ncbi.nlm.nih.gov/pubmed/27186130 http://dx.doi.org/10.2147/JEP.S28553 |
Ejemplares similares
-
Hedgehog signalling in colon cancer and stem cells
por: Gulino, Alberto, et al.
Publicado: (2009) -
In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
por: Benvenuto, Monica, et al.
Publicado: (2016) -
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors
por: Infante, Paola, et al.
Publicado: (2015) -
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2
por: Spiombi, Eleonora, et al.
Publicado: (2019) -
Evaluation of the ‘Hedgehog’ signaling pathways in squamous and basal cell carcinomas of the eyelids and conjunctiva
por: CELEBI, ALI RIZA CENK, et al.
Publicado: (2016)